Day: March 18, 2021

New York City, March 18, 2021 (GLOBE NEWSWIRE) — BUZZ announced stocks added and removed from its flagship Index according to its regularly scheduled monthly rebalance. The Index changes are based on the latest measures of positive investor sentiment. BUZZ uses analytics models featuring Artificial Intelligence and Natural Language Processing technologies to scan over 15 million stock-specific online posts per month, identifying those stocks with the highest levels of aggregate investor sentiment. Each month, the 75 stocks with the highest scores are featured in the BUZZ Index and weighted according to their positive sentiment rank. The March rebalance features eleven new stocks added and removed from the Index, including: BUZZ CEO, Jamie Wise explains, “Monthly rebalancing allows us to keep a pulse on the market to ensure we are...

HERZLIYA, Israel, March 18, 2021 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a year-end business update. Significant events and achievements during the fourth quarter 2020 and subsequent period:Preparation for the first Phase 3 clinical trial, for patients undergoing bunionectomy surgery, is expected to begin by mid-2021Announced the engagement of Lotus Clinical Research as the Company’s clinical research organization to conduct the Phase 3 clinical trials under the leadership of Dr. Neil SinglaAnnounced the appointment of Rita Keynan as Vice President of Pharmaceutical OperationsSigned a manufacturing services and quality agreement with a subcontractor for GMP manufacturing...

THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.VANCOUVER, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) — FPX Nickel Corp. (FPX-TSX.V) (“FPX” or the “Company”) announces that it has entered into an amendment (the “Amendment”) to its previously announced agreement with Paradigm Capital Inc. and Cormark Securities Inc. (the “Underwriters”), pursuant to which the Underwriters have agreed to increase the size of the bought deal financing. Pursuant to the Amendment, the Underwriters will purchase, on a bought deal basis, an aggregate of 21,539,000 common shares (the “Common Shares”) at an offering price of $0.65 per Common Share (the “Issue Price”) for gross proceeds of approximately $14 million (the “Offering”).The Company has granted the Underwriters an...

NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) has scheduled its First Quarter 2021 financial results announcement.Senior management will be available for questions from the investment community following prepared remarks.All participants can access the conference via webcast through the Nasdaq Investor Relations website at: http://ir.nasdaq.com/. An audio replay of the conference will be available after the call on the Nasdaq Investor Relations website or by dialing 855-859-2056 (U.S.) or 404-537-3406 (International); Conference ID: 6783237.Note: The press release for the First Quarter 2021 results will be posted on the Nasdaq Investor Relations website at http://ir.nasdaq.com/ on Wednesday, April 21, 2021 at approximately 7:00 AM Eastern.About NasdaqNasdaq (Nasdaq: NDAQ) is a global technology company serving...

ARQ-252 is a potent and highly selective topical JAK1 inhibitor offering potential safety advantages over less selective JAK inhibitorsTopline data anticipated second half 2023Vitiligo affects approximately 1.3 million patients in the U.S.WESTLAKE VILLAGE, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced enrollment of the first patient in a Phase 2a clinical trial evaluating ARQ-252 as a potential treatment for vitiligo. ARQ-252 is a potent and highly selective topical small molecule inhibitor of Janus kinase type 1 (JAK1).“Initiation of this clinical trial marks an important milestone toward...

Launching additional 40 nodes, increasing total staked to 7,680 ETH valued at approx. $13.8MSilver Spring, MD, March 18, 2021 (GLOBE NEWSWIRE) — BTCS Inc. (OTCQB: BTCS) (“BTCS” or the “Company”), a digital asset and blockchain technology focused company, today announced its recently expanded transaction verification services operation on ethereum 2.0 is fully operational with all 200 nodes generating revenue. The Company expects to launch an additional 40 nodes, expanding its staking operation to 240 nodes, with the additional nodes anticipated to commence revenue generation before the end of March 2021.$1.1 Million Revenue Potential from Current Staking OperationThe Company has staked a total of 7,680 ETH in its ethereum 2.0 transaction verification services operation, which has the potential to generate $1.1 million in annual...

VANCOUVER, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (DMGGF:OTCQB US) (FRANKFURT:6AX) (“DMG” or the “Company”), a vertically integrated blockchain and cryptocurrency technology company, today announces that its Board of Directors has approved, along with its self-mining, to incorporate a Bitcoin accumulation strategy to significantly increase the Company’s Bitcoin (“BTC”) treasury holdings. After watching for buying opportunities in the market over the last few days and weeks, DMG has started to implement this plan by executing Bitcoin purchases in the amount of roughly 220 BTC since Monday afternoon through customary cryptocurrency exchanges and direct over-the-counter (“OTC”) trades. DMG intends to periodically purchase BTC, based on market conditions, trends and corporate...

San Diego, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, announced today that Punit Dhillon, CEO, Skye Bioscience will participate in a virtual panel discussion and present a corporate overview at the Benzinga Biotech Small Cap Conference on Thursday, March 25, 2021. Details are as follows:Panel DiscussionTitle: The Natural Solutions: Cannabis & CannabinoidsTime: 11:40 AM ESTRegistration Link: http://bit.ly/2NxSShiCorporate OverviewTitle: Unlocking the Pharmaceutical Potential of CannabinoidsTime: 12:10 PM ESTRegistration Link: http://bit.ly/2NxSShiFor more information about this event, please visit: https://www.benzinga.com/events/small-cap/biotech/About...

HOUSTON, March 18, 2021 (GLOBE NEWSWIRE) — Recruiter.com Group, Inc. (OTCQB: RCRT), a leading AI-powered and video hiring platform with the world’s largest network of recruiters, has announced today that Robert Heath, Executive Vice President, RPX Corporation, and Steve Pemberton, Chief Human Resources Officer, Workhuman, have been appointed as independent directors of the Company.“We are honored to welcome Robert Heath and Steve Pemberton to the Recruiter.com board of directors,” said Evan Sohn, Executive Chairman of Recruiter.com. “Robert, with his deep knowledge and experience in M&A and company diversification, will serve as a guiding force as we continue to expand and scale the Recruiter.com brand and product offerings. And Steve, who is a leading expert in building inspiring workplaces, will ensure...

The New Firm is Developing New Technologies for Water & Soil RemediationCORSICANA, TX, March 18, 2021 (GLOBE NEWSWIRE) — Midwest Energy Emissions Corp. (OTCQB: MEEC) (“ME2C Environmental” or the “Company”), a leading environmental technologies firm, today announced its participation in the creation of a new technologies firm, Eleclear Technologies, LLC.Eleclear Technologies is based in Alabama and will be initially funded with $1.2 Million of new capital on a 70/30 basis between Dr. Scott A Drummond and ME2C Environmental to coincide with the ownership arrangement. ME2C Environmental will provide technical and research direction, along with the commercialization of the anticipated technologies. The initial technologies being developed by Eleclear will move to full pilot scale testing in the near future.“Our collaboration...